Scott Mclean Hanson Sells 7,000 Shares of Ambiq Micro (NYSE:AMBQ) Stock

Ambiq Micro, Inc. (NYSE:AMBQ) CTO Scott Mclean Hanson sold 7,000 shares of the stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $64.38, for a total transaction of $450,660.00. Following the sale, the chief technology officer owned 211,226 shares of the company’s stock, valued at approximately $13,598,729.88. This represents a 3.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ambiq Micro Price Performance

NYSE AMBQ opened at $59.51 on Thursday. Ambiq Micro, Inc. has a 1 year low of $22.12 and a 1 year high of $91.61. The stock has a market capitalization of $1.44 billion and a PE ratio of -28.07. The business’s 50-day moving average is $75.47 and its 200 day moving average is $53.59.

Ambiq Micro (NYSE:AMBQ) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.07) EPS for the quarter. Ambiq Micro had a negative net margin of 37.77% and a negative return on equity of 11.85%. The business had revenue of $33.90 million for the quarter. Ambiq Micro has set its Q3 2026 guidance at -0.200–0.120 EPS. As a group, equities research analysts anticipate that Ambiq Micro, Inc. will post -1.69 earnings per share for the current year.

Institutional Trading of Ambiq Micro

A number of hedge funds have recently modified their holdings of AMBQ. Rhumbline Advisers purchased a new stake in shares of Ambiq Micro in the 3rd quarter worth about $119,000. JPMorgan Chase & Co. purchased a new position in Ambiq Micro during the 3rd quarter valued at about $56,000. Vanguard Group Inc. bought a new stake in Ambiq Micro during the third quarter worth about $9,210,000. Franklin Resources Inc. bought a new stake in Ambiq Micro during the third quarter worth about $358,000. Finally, BNP Paribas Financial Markets purchased a new stake in Ambiq Micro in the third quarter worth about $28,000.

Wall Street Analysts Forecast Growth

AMBQ has been the topic of several recent analyst reports. Needham & Company LLC lifted their price target on shares of Ambiq Micro from $70.00 to $85.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Weiss Ratings restated a “sell (d-)” rating on shares of Ambiq Micro in a report on Monday, June 29th. Northland Securities set a $81.00 target price on shares of Ambiq Micro in a research report on Wednesday, August 12th. Citigroup reaffirmed a “neutral” rating on shares of Ambiq Micro in a research note on Tuesday, August 11th. Finally, Roth Capital started coverage on shares of Ambiq Micro in a research report on Monday, July 13th. They set a “buy” rating and a $125.00 price target on the stock. Four investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Ambiq Micro has a consensus rating of “Hold” and an average target price of $76.00.

Ambiq Micro Company Profile

Ambiq Micro (NYSE: AMBQ) is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company’s core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq’s products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.

The company’s flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.